News
2026-02-17
Cellectricon strengthens its presence in Japan
MÖLNDAL, SWEDEN Cellectricon is pleased to announce a strategic collaboration with Biosector and Stefan Sandström, aimed at strengthening the company’s...
Events
March 17-21, 2026
AD/PD 2026
The AD/PD 2026 International Conference on Alzheimer’s and Parkinson’s Diseases and related neurological disorders takes place in Copenhagen, Denmark on...
Events
March 12, 2026
Live webinar - In vitro neuronal models for assessment of delayed onset neuroinflammatory toxicity effects of ASOs
This webinar takes place on Thursday March 12 between 16.00 and 16.30 CET / 15.00-15.30 GMT / 11.00-11.30 AM EDT / 8.00-8.30 AM...

Sign up to get news & events updates from Cellectricon

Read about our Privacy Policy

Events
February 24-26, 2026
Bio-Neuroscience
The Bio-Neuroscience meeting takes place in Amsterdam, the Netherlands on February 24-26. The meeting brings together leading CEOs, investors, executives...
Events
February 3-5, 2026
Alzheimer’s & Parkinson’s Drug Development Summit
The Alzheimer’s & Parkinson’s Drug Development Summit takes place in Boston, US on February 3-5. The meeting brings together experts...
Events
January 27-29, 2026
Non-Opioid Pain Therapeutics Summit
The Non-Opioid Pain Therapeutics Summit takes place in Boston, US on January 27-29. The meeting brings together experts in pain...

Sign up to get news & events updates from Cellectricon

Read about our Privacy Policy

Events
NEW DATE: January 22, 2026
Live webinar - A translationally relevant assay platform for assessment of acute onset antisense oligonucleotide-induced neurotoxicity
This webinar takes place on Thursday January 22nd between 16.00 and 16.30 CET / 15.00-15.30 GMT / 10.00-10.30 AM EST / 7.00-7.30...
News
2025-11-13
Cellectricon and CCRM Nordic announce strategic partnership
We are excited to announce a new collaboration with CCRM Nordic, the Nordic centre for advanced therapy medicinal products (ATMPs)....
News
2025-10-30
Cellectricon launches Neurotoxicity Testing Services
MÖLNDAL, SWEDEN Cellectricon, a services provider dedicated to advancing neuroscience drug discovery, today announced the launch of its new Neurotoxicity...